PLASMA CELL DISORDERS

Clinical trials for PLASMA CELL DISORDERS explained in plain language.

Never miss a new study

Get alerted when new PLASMA CELL DISORDERS trials appear

Sign up with your email to follow new studies for PLASMA CELL DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy targets rare bone cancer with immune-boosting drug

Disease control Recruiting now

This study tests whether combining radiation with a bispecific antibody (CM336) can safely treat solitary bone plasmacytoma that has mild bone marrow involvement. About 21 adults with this rare plasma cell disorder will receive the combination therapy. The goal is to control the …

Matched conditions: PLASMA CELL DISORDERS

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 14, 2026 12:01 UTC

PLASMA CELL DISORDERS

Get alerted when new PLASMA CELL DISORDERS trials appear

New combo therapy targets rare bone cancer with immune-boosting drug